Navigation Links
The most natural drug
Date:4/30/2008

In the fight against infection, the human immune system isnt ready for a war.

Vaccines push the immune system to create defenses against illness, but they take time to work. A new process developed by scientists at the Oklahoma Medical Research Foundation (OMRF) and Emory University stands to revolutionize the process.

In an advance online publication in Nature, the researchers describe a method that can identify and clone human antibodies specifically tailored to fight infections. The new technology holds the potential to quickly and effectively create new treatments for influenza and a variety of other communicable diseases.

When an infection invades, the immune system goes to work manufacturing antibodies to fight it. Most of the antibodies created will have no effect, but a very few will bond to the invader and replicate to neutralize the enemy.

The new process develops a smart bomb for the immune system, using fully human monoclonal antibodies specifically designed to fight the infection without doing any harm to the body. The work was led by OMRFs Patrick Wilson, Ph.D., and J. Donald Capra, M.D., and Emorys Rafi Ahmed, Ph.D., and Jens Wrammert, Ph.D.

In the past, it took years of work and great expense to create what are known as monoclonal antibodieslab-produced antibodies derived from a single line of cells. It was kind of the needle in a haystack approach, said OMRFs Wilson, senior author on the paper. The problem is they couldnt pick the cells that made the antibodies against the pathogens that you wanted to fight.

A second method, making hybrid antibodies from mouse B cells (white blood cells that produce infection-fighting antibodies), is faster but more dangerous. If the proteins in the hybrid antibodies werent compatible, the body could reject the antibodies or react with them in unforeseen ways.

The new process doesnt use traditional antibody derivation methods or human-mouse hybrids. Instead, the OMRF and Emory researchers isolated antibody-secreting cells (plasma cells) from people who had received the influenza vaccine, then cloned the antibody genes from these cells.

We can recognize which cells are made and then make antibodies from them directly, Wilson said. Its a rapid and efficient way to make fully human antibodies.

While the research is aimed at combating influenza, it can be used to create treatments for any conditionsuch as anthrax or smallpoxfor which there is already a vaccine. Antibodies might also be produced from the immune responses of people with active or chronic infections. This technology has the potential to serve as therapy for someone who is already infected or provide passive immunity to protect against future infection.

Vaccines can activate the immune system, but they need time to take effect, and many offer less than 100 percent protection and carry risks of side effects, OMRF President Stephen Prescott, M.D., said. With further research and testing, this new method might allow a nurse going into the center of an outbreak to receive a shot to keep her safe from infection. Soldiers in the field could keep a shot of anti-anthrax in their packs in case of a biological attack.

With more research, this new technology could also be key to fighting diseases such as multiple sclerosis and cancer, Prescott said.

Wilson and his clinical collaborator, OMRFs Judith James, M.D., Ph.D., are currently working to make more antibodies from other infectionsincluding hepatitis C, pneumococcal pneumonia, and anthrax. Theyre also seeking a partner to help produce large quantities of the influenza antibodies.

We now have an outstanding opportunity to create antibodies against a host of diseases, James said. This discovery has great clinical potential.


'/>"/>

Contact: Adam Cohen
adam-cohen@omrf.org
405-271-7159
Oklahoma Medical Research Foundation
Source:Eurekalert

Related biology technology :

1. FDA Clears First Medical Product Made From Yulex(R) Natural Rubber
2. AGI Dermatics Clinical Data Identifies L-Ergothioneine as Part of Skins Natural Antioxidant System
3. Natural Nutrition Launches International Marketing Campaign for New All Natural Analgesic: BLUE LIGHTNING(TM) Fast Pain Relief
4. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... IPSWICH, Mass. , Feb. 17, 2017 /PRNewswire/ ... a small tumor had a mutation-conferring resistance to ... treatment. Recently, genomics research has focused on finding ... — or even from circulating tumor DNA in ... identify new oncology therapeutics. Unfortunately, however, ...
(Date:2/16/2017)... ... February 16, 2017 , ... EIT Digital has launched work ... agricultural industry. Pilot studies are about to get under way for the framework, which ... 5G innovations. The concept is expected to be transferred eventually to other industries that ...
(Date:2/16/2017)... and GREENWICH, Conn. , ... investment firm focused on venture growth investments in ... of Josh Richardson , M.D. to Managing ... in biotechnology companies.  He is a board observer ... roles in Longitude,s investments in Aimmune Therapeutics, Akebia ...
(Date:2/16/2017)... Research and Markets has announced the addition ... to their offering. ... The study scope includes ... chassis organisms, synthetic cells, production systems), enabling technologies (DNA ... specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, agriculture) ...
Breaking Biology Technology:
(Date:2/13/2017)...  RSA Conference -- RSA, a Dell Technologies business, ... enhance fraud detection and investigation across digital environments ... & Risk Intelligence Suite. The new platform is ... from internal and external sources as well as ... from targeted cybercrime attacks. "Fraudsters are ...
(Date:2/8/2017)... About Voice Recognition Biometrics Voice recognition biometrics ... a stored voiceprint template. Acoustic features of an ... are compared to distinguish between individual voices. Voice ... PCs already have a microphone and can authenticate ... are most likely to be deployed in telephone-based ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
Breaking Biology News(10 mins):